Access to the Corporate Investors' Complementary Resources: A Leverage for Innovation in Biotech Venture Capital-Backed Companies
Authors:
- Fatima ShuwaikhFSFatima Shuwaikh
- Emmanuelle DubocageEDEmmanuelle Dubocage
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Technological Forecasting and Social Change
- Vol. 175
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Tapping into the knowledge of incumbents: The role of corporate venture capital investments and inventor mobilityStrategic Entrepreneurship Journal, 2018
- Are entrepreneurial venture's innovation rates sensitive to investor complementary assets? Comparing biotech ventures backed by corporate and independent VCsStrategic Management Journal, 2014
- The Selection and Nurturing Effects of Corporate Investors on New Venture InnovativenessStrategic Entrepreneurship Journal, 2013
- Technological overlap, technological capabilities, and resource recombination in technological acquisitionsStrategic Management Journal, 2013
- Are all ‘sharks’ dangerous? new biotechnology ventures and partner selection in R&D alliancesStrategic Management Journal, 2012
- The scope and governance of international R&D alliancesStrategic Management Journal, 2004
- Technological acquisitions and the innovation performance of acquiring firms: a longitudinal studyStrategic Management Journal, 2001
- Relative absorptive capacity and interorganizational learningStrategic Management Journal, 1998
- Value creation in acquisitions: A re‐examination of performance issuesStrategic Management Journal, 1990
- A resource‐based view of the firmStrategic Management Journal, 1984